Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 1
2004 2
2006 2
2011 1
2012 1
2014 3
2016 1
2017 1
2019 1
2020 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
Hackmon R, Blichowski M, Koren G. Hackmon R, et al. J Obstet Gynaecol Can. 2012 Nov;34(11):1077-1086. doi: 10.1016/S1701-2163(16)35438-X. J Obstet Gynaecol Can. 2012. PMID: 23231846 Review.
Traditionally, MMI has been considered to have clearer evidence of teratogenicity than PTU. Recent studies suggest that PTU can be hepatotoxic, leading to a United States Food and Drug Administration "black box alert." We wished to …
Traditionally, MMI has been considered to have clearer evidence of teratogenicity than PTU. Recent studies suggest that PTU can be he …
Gastrointestinal endoscopy in pregnancy.
Savas N. Savas N. World J Gastroenterol. 2014 Nov 7;20(41):15241-52. doi: 10.3748/wjg.v20.i41.15241. World J Gastroenterol. 2014. PMID: 25386072 Free PMC article. Review.
Gastrointestinal endoscopy has a major diagnostic and therapeutic role in most gastrointestinal disorders; however, limited information is available about clinical efficacy and safety in pregnant patients. The major risks of endoscopy during pregnancy include potent …
Gastrointestinal endoscopy has a major diagnostic and therapeutic role in most gastrointestinal disorders; however, limited information is a …
Pregnancy exposure registries.
Kennedy DL, Uhl K, Kweder SL. Kennedy DL, et al. Drug Saf. 2004;27(4):215-28. doi: 10.2165/00002018-200427040-00001. Drug Saf. 2004. PMID: 15003034 Review.
Scientifically valid data on the safety of drug use during pregnancy are a significant public health need. ...Therefore, post-marketing pregnancy exposure registries are being increasingly used to proactively monitor for major fetal effects and …
Scientifically valid data on the safety of drug use during pregnancy are a significant public health need. ...Therefore …
Evolving knowledge of the teratogenicity of medications in human pregnancy.
Adam MP, Polifka JE, Friedman JM. Adam MP, et al. Am J Med Genet C Semin Med Genet. 2011 Aug 15;157C(3):175-82. doi: 10.1002/ajmg.c.30313. Epub 2011 Jul 15. Am J Med Genet C Semin Med Genet. 2011. PMID: 21766440 Review.
We reviewed the safety during pregnancy of 172 drugs approved by the US Food and Drug Administration (FDA) from 2000 to 2010 using the TERIS risk rating system. ...The teratogenic risk in human pregnancy was "undetermined" for 168 …
We reviewed the safety during pregnancy of 172 drugs approved by the US Food and Drug Administration (FDA …
Gastrointestinal endoscopy in the pregnant woman.
Friedel D, Stavropoulos S, Iqbal S, Cappell MS. Friedel D, et al. World J Gastrointest Endosc. 2014 May 16;6(5):156-67. doi: 10.4253/wjge.v6.i5.156. World J Gastrointest Endosc. 2014. PMID: 24891928 Free PMC article. Review.
About 20000 gastrointestinal endoscopies are performed annually in America in pregnant women. Gastrointestinal endoscopy during pregnancy raises the critical issue of fetal safety in addition to patient safety. Endoscopic medications may be potentially aborti …
About 20000 gastrointestinal endoscopies are performed annually in America in pregnant women. Gastrointestinal endoscopy during pregnancy …
Use of Topical Tazarotene for the Treatment of Acne Vulgaris in Pregnancy: A Literature Review.
Han G, Wu JJ, Del Rosso JQ. Han G, et al. J Clin Aesthet Dermatol. 2020 Sep;13(9):E59-E65. Epub 2020 Sep 1. J Clin Aesthet Dermatol. 2020. PMID: 33133344 Free PMC article. Review.
A concern with the increasing use of prescription drugs during pregnancy is teratogenic risk. This risk is undetermined for most drugs approved in the United States (US) from 2000 to 2010. ...In terms of topical tazarotene, there are currently limited …
A concern with the increasing use of prescription drugs during pregnancy is teratogenic risk. This risk is undetermined for mo …
A systematic review of pregnancy exposure registries: examination of protocol-specified pregnancy outcomes, target sample size, and comparator selection.
Gelperin K, Hammad H, Leishear K, Bird ST, Taylor L, Hampp C, Sahin L. Gelperin K, et al. Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):208-214. doi: 10.1002/pds.4150. Epub 2016 Dec 27. Pharmacoepidemiol Drug Saf. 2017. PMID: 28028914
PURPOSE: Our study sought to systematically evaluate protocol-specified study methodology in prospective pregnancy exposure registries including pre-specified pregnancy outcomes, power calculations for sample size, and comparator group selection. METHODS: U.S …
PURPOSE: Our study sought to systematically evaluate protocol-specified study methodology in prospective pregnancy exposure re …
Comparative effectiveness of risk mitigation strategies to prevent fetal exposure to mycophenolate.
Sarayani A, Albogami Y, Elkhider M, Hincapie-Castillo JM, Brumback BA, Winterstein AG. Sarayani A, et al. BMJ Qual Saf. 2020 Aug;29(8):636-644. doi: 10.1136/bmjqs-2019-010098. Epub 2019 Oct 24. BMJ Qual Saf. 2020. PMID: 31649165
BACKGROUND: In 2012, the US Food and Drug Administration approved a Risk Evaluation and Mitigation Strategy (REMS) programme including mandatory prescriber training and a patient/provider acknowledgement form to prevent fetal exposure to mycophenolate. …
BACKGROUND: In 2012, the US Food and Drug Administration approved a Risk Evaluation and Mitigation Strategy (REMS) prog …
Pregnancy-related adverse events associated with statins: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS).
Wu T, Shi Y, Zhu B, Li D, Li Z, Zhao Z, Zhang Y. Wu T, et al. Expert Opin Drug Saf. 2024 Mar;23(3):313-321. doi: 10.1080/14740338.2023.2251888. Epub 2023 Sep 1. Expert Opin Drug Saf. 2024. PMID: 37612600
BACKGROUND: Statins, previously rated as pregnancy category X agents, were contraindicated during pregnancy due to the teratogenic effects observed in animal studies. However, it is still controversial whether statins have detrimental impact on pregnant women …
BACKGROUND: Statins, previously rated as pregnancy category X agents, were contraindicated during pregnancy due to the tera …
Teratogenesis and immunosuppressive treatment.
Danesi R, Del Tacca M. Danesi R, et al. Transplant Proc. 2004 Apr;36(3):705-7. doi: 10.1016/j.transproceed.2004.03.017. Transplant Proc. 2004. PMID: 15110638
Despite the potential risks to the mother and fetus caused by immunosuppressive drugs, uneventful pregnancies are now frequent among transplant recipients. Although there is no apparent increase in the type or incidence of malformations in the newborns or evidence of graft …
Despite the potential risks to the mother and fetus caused by immunosuppressive drugs, uneventful pregnancies are now frequent among …
15 results